28 Stocks Moving in Friday’s Pre-Market Session
Gainers
Sphere 3D Corp. (NASDAQ: ANY) shares rose 35.4% to $4.66 in pre-market trading after the company reported an Agreement to acquire exclusive rights for assignment of cryptocurrency mining assets.
Goldman Sachs Initiates Coverage On Dynavax Technologies with Buy Rating, Announces Price Target of $19
Goldman Sachs analyst Madhu Kumar initiates coverage on Dynavax Technologies (NASDAQ:DVAX) with a Buy rating and announces Price Target of $19.
10 Biggest Price Target Changes For Thursday
Keybanc boosted the price target for HubSpot, Inc. (NYSE: HUBS) from $697 to $711. HubSpot shares rose 1.1% to close at $590.00 on Wednesday.
HC Wainwright & Co. Maintains Buy on Dynavax Technologies, Raises Price Target to $20
HC Wainwright & Co. analyst Edward White maintains Dynavax Technologies (NASDAQ:DVAX) with a Buy and raises the price target from $16 to $20.
Dynavax Technologies Q2 EPS $0.02 Beats $(0.04) Estimate, Sales $52.77M Beat $41.59M Estimate
Dynavax Technologies (NASDAQ:DVAX) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.04) by 150 percent. This is a 103.77 percent increase over losses of $(0.53) per share
Earnings Scheduled For August 4, 2021
Companies Reporting Before The Bell
• UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies.
Dynavax Shares Tick Higher On Volume Following Sam.gov Contract Opportunity From CDC For Co.’s ‘2021 Vaccines For Adults (VFA)’
https://sam.gov/opp/c1c809730e944fd99e76b20416d40cc2/view
Clover, Dynavax Ink Commercial Supply Agreement For CpG 1018 Adjuvant
Clover Biopharmaceuticals and Dynavax Technologies Corporation (NASDAQ:DVAX) have executed the commercial supply agreement of Dynavax’s CpG 1018TM advanced adjuvant for use in Clover’s…